Bifiasthm®
Product description
Bifiasthm is a probiotic product proposed for children
with asthma, in order to prevent asthmatic crises and support the balance of
the immune system reactivitity. Bifiasthm is based on B. breve B632 and L.
salivarius LS01, two strains with immunomodulatory activity targeted for
allergic asthmatic subjects. A placebo-controlled clinical trial pending
publication in 2020 and involving 500 asthmatic children showed that Bifiasthm
was able to reduce significantly the episodes of asthma.
Read more
Specifications
Categories | Finished Dosage Forms; Natural ExtractsFunctional Food And Nutraceutical Ingredients; APIs (Active Pharmaceutical Ingredients)Probiotics |
---|---|
Sales markets | Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Asia; Oceania; North America (USA, Canada); Africa; Central/South America |
Supplied from | Italy |
Selling Points | Product Features; Quality Service |
Products from other suppliers
❮
❯
-
VALSARIN 80/VALSARIN 160/VALSARIN 320
-
NURONORM
-
DERMOGEL NEW to treat inflammatory skin conditions
-
Anlitin (Levonorgestrel 1.5 mg) Tablet
-
Levocarnitine (LEKARNITIN) 1 G/5 ML SOLUTION FOR I.V. INJECTION
-
FOOD GRADE EPOXY COATING FOR INTERNAL POTABLE TANK PIPELINE - CLEAN TECH PW
-
Synatura Syrup
-
Ectoin® Allergy Eye Drops 2% - The innovation for treatment and prevention of allergic conjunctivitis symptoms
-
Kalmosan Skin Lotion
-
ComBE Five Pentavalent DTP-HepB-Hib
Bifiasthm®
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation